Venture Capital · Menlo Park (United States), Shanghai (China), New York (United States) · Founded 2012
Decheng Capital is a global life sciences investment firm providing capital and strategic support to early-stage and growth-stage healthcare companies. They focus on companies with revolutionary technologies and strong market presence. Founded in 2012, Decheng has over $2 billion in capital.
Series A, Series B, Series C
BioTech, Diagnostics, Healthcare, MedTech
Unlock for 1 credit to view portfolio companies and the full investment list.
Unlock for 1 credit to view team members and contact details.
Unlock for 1 credit to view website, LinkedIn, and other firm links.